Pure Global AI
NCT05958901Recruiting

Pulmonary Hypertension Observational Study

A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)
The First Affiliated Hospital of Guangzhou Medical UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
pulmonary hypertension
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
The First Affiliated Hospital of Guangzhou Medical University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jul 12, 2023
End date
Dec 30, 2027
Enrollment
10000 participants
Primary outcome

mean pulmonary arterial pressure

Summary

The purpose of this study is to establish the large PH cohort and biological database in
 China, aiming for precision medicine to optimize diagnosis and treatment choices.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05958901
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05958901 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Guangzhou Medical University and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 10000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.